BIONUMERIK PHARMACEUTICALS

BioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment of cancer. The company’s two oncology drug candidates, Tavocept and BNP1350, are in late-stage clinical development. BioNumerik Pharmaceuticals, Inc. was founded in 1992 and is based in San Antonio, Texas.

#People #Financial #Website #More

BIONUMERIK PHARMACEUTICALS

Industry:

Biotechnology Health Care Medical Device Pharmaceutical

Founded:

1992-01-01

Address:

San Antonio, Texas, United States

Country:

United States

Website Url:

http://www.bionumerik.com

Total Employee:

51+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

63.32 M USD

Technology used in webpage:

GoDaddy DNS Person Schema Gravatar Profiles Linode

Current Employees Featured

not_available_image

Stacey Bain
Stacey Bain Vice President of Clinical Product Development @ BioNumerik Pharmaceuticals
Vice President of Clinical Product Development

frederick-h-hausheer_image

Frederick H. Hausheer
Frederick H. Hausheer Founder and CEO @ BioNumerik Pharmaceuticals
Founder and CEO

Founder

frederick-h-hausheer_image

Frederick H. Hausheer

Investors List

takeda-pharmaceutical_image

Takeda

Takeda investment in Corporate Round - BioNumerik Pharmaceuticals

Official Site Inspections

http://www.bionumerik.com

Host Informations
Whois Informations

Loading ...

More informations about "BioNumerik Pharmaceuticals" on Search Engine